News
The label for Marlex Pharmaceuticals Digoxin .125 mg strength tablets. FDA Digoxin 0.25 mg tablets, lot No. E3811, expiration 2/2025, NDC No. 10135-0748-01.
Digoxin Tablets USP, 0.125 mg are yellow, circular, beveled, uncoated tablets that are scored between “N” and “201″ on one side and plain on the other side.
The label for Marlex Pharmaceuticals Digoxin .125 mg strength tablets. Digoxin 0.25 mg tablets, lot No. E3811, expiration 2/2025, NDC No. 10135-0748-01.
New Castle, Delaware, Marlex Pharmaceuticals, Inc. is voluntarily recalling one lot of Digoxin Tablets USP, 0.125mg and one lot of Digoxin Tablets USP, 0.25mg to the consumer level due to Label ...
If digoxin is the best option, then your health care team will begin the process of setting your digoxin dosage. They will consider your height, weight, gender, age, and any other health ...
Hosted on MSN12mon
JAMP Pharma's digoxin tablets recalled for possible dosing issue - MSNJAMP Pharma Corporation is recalling its digoxin tablets because some bottles may contain an incorrect dose, Health Canada announced in an advisory. The drug-maker said its 0.0625 and 0.125 mg ...
Digoxin 0.125mg Tablet – NDC 10135-0747-01, lot No. E3810, expiration 2/2025. Digoxin 0.25mg Tablet – NDC 10135-0748-01, lot No. E3811, expiration 2/2025.
The label for Marlex Pharmaceuticals Digoxin .125 mg strength tablets. FDA Digoxin 0.25 mg tablets, lot No. E3811, expiration 2/2025, NDC No. 10135-0748-01.
The label for Marlex Pharmaceuticals Digoxin .125 mg strength tablets. FDA Digoxin 0.25 mg tablets, lot No. E3811, expiration 2/2025, NDC No. 10135-0748-01.
The label for Marlex Pharmaceuticals Digoxin .125 mg strength tablets. FDA Digoxin 0.25 mg tablets, lot No. E3811, expiration 2/2025, NDC No. 10135-0748-01.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback